Bharat Immunologicals & Biologicals Corporation Limited (BOM:524663)

BOM:524663 Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2023	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Cash & Equivalents	89.09	12.86	46.43	12.27	9.85	4.08
Short-Term Investments	-	-	-	-	-	21.01
Cash & Short-Term Investments	89.09	12.86	46.43	12.27	9.85	25.09
Cash Growth	9.39%	-72.30%	278.40%	24.57%	-60.73%	-82.85%
Accounts Receivable	100.26	138.76	11.33	0.12	188.01	729.72
Other Receivables	-	39.4	32.43	29.23	-	4.52
Receivables	100.26	178.16	43.76	29.35	188.01	734.24
Inventory	14.24	14.22	362.5	134.9	517.19	144.39
Prepaid Expenses	-	0.12	1.68	-	0.01	0.04
Other Current Assets	123.51	152.67	199.92	163.02	215.14	83.61
Total Current Assets	327.1	358.03	654.29	339.54	930.2	987.35
Property, Plant & Equipment	1,152	1,157	1,160	361.28	46.84	49.21
Long-Term Investments	92.82	-	-	-	-	-
Long-Term Deferred Tax Assets	297.64	266.55	210.26	200.93	139.98	100.09
Other Long-Term Assets	11.61	104.43	102.93	138.11	151.28	112.96
Total Assets	1,881	1,886	2,127	1,040	1,268	1,250
Accounts Payable	7.79	10.31	8.69	147.93	435.32	441.84
Accrued Expenses	-	63.6	55.52	46.42	16.04	10.08
Short-Term Debt	708.64	702.25	778.85	272.93	30.38	322.22
Current Unearned Revenue	-	90.66	112	93.83	119.59	70.03
Other Current Liabilities	274.12	73.6	57.58	79.8	405.75	40.58
Total Current Liabilities	990.55	940.42	1,013	640.91	1,007	884.75
Long-Term Unearned Revenue	-	-	-	-	-	4.8
Other Long-Term Liabilities	68.68	0.72	0.72	0.72	1.35	-
Total Liabilities	1,094	1,004	1,074	699.45	1,064	942.83
Common Stock	431.8	431.8	431.8	431.8	431.8	431.8
Retained Earnings	-	-662.11	-495.73	-408.19	-227.14	-125.03
Comprehensive Income & Other	355.29	1,112	1,117	316.8	0.08	-
Shareholders' Equity	787.09	882.14	1,054	340.41	204.74	306.77
Total Liabilities & Equity	1,881	1,886	2,127	1,040	1,268	1,250
Total Debt	743.64	702.25	778.85	272.93	30.38	322.22
Net Cash (Debt)	-654.55	-689.39	-732.42	-260.66	-20.53	-297.14
Net Cash Per Share	-15.16	-15.97	-16.96	-6.04	-0.48	-6.88
Filing Date Shares Outstanding	43.14	43.18	43.18	43.18	43.18	43.18
Total Common Shares Outstanding	43.14	43.18	43.18	43.18	43.18	43.18
Working Capital	-663.45	-582.4	-358.35	-301.37	-76.87	102.6
Book Value Per Share	18.24	20.43	24.40	7.88	4.74	7.10
Tangible Book Value	787.09	882.14	1,054	340.41	204.74	306.77
Tangible Book Value Per Share	18.24	20.43	24.40	7.88	4.74	7.10
Land	-	1,123	1,128	8.35	8.35	8.35
Buildings	-	123.68	123.68	123.68	123.68	19.82
Machinery	-	323.32	323.32	323.12	323.32	31.44
Construction In Progress	-	-	-	319	2.19	2.19

Source: S&P Global Market Intelligence. Standard template. Financial Sources.